NL184836C - Werkwijze voor het bereiden van anti-inflammatoir werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van anti-inflammatoir werkzame oxazolopyridinen. - Google Patents

Werkwijze voor het bereiden van anti-inflammatoir werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van anti-inflammatoir werkzame oxazolopyridinen.

Info

Publication number
NL184836C
NL184836C NLAANVRAGE7307582,A NL7307582A NL184836C NL 184836 C NL184836 C NL 184836C NL 7307582 A NL7307582 A NL 7307582A NL 184836 C NL184836 C NL 184836C
Authority
NL
Netherlands
Prior art keywords
inflammatic
preparing anti
active
oxazolopyridins
pharmaceutical preparations
Prior art date
Application number
NLAANVRAGE7307582,A
Other languages
English (en)
Other versions
NL7307582A (nl
NL184836B (nl
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NL7307582A publication Critical patent/NL7307582A/xx
Publication of NL184836B publication Critical patent/NL184836B/nl
Application granted granted Critical
Publication of NL184836C publication Critical patent/NL184836C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NLAANVRAGE7307582,A 1972-06-14 1973-05-30 Werkwijze voor het bereiden van anti-inflammatoir werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van anti-inflammatoir werkzame oxazolopyridinen. NL184836C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26289872A 1972-06-14 1972-06-14
BE147896A BE819177R (fr) 1972-06-14 1974-08-26 Oxazolo- et thiazolopyridines

Publications (3)

Publication Number Publication Date
NL7307582A NL7307582A (nl) 1973-12-18
NL184836B NL184836B (nl) 1989-06-16
NL184836C true NL184836C (nl) 1989-11-16

Family

ID=25648082

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7307582,A NL184836C (nl) 1972-06-14 1973-05-30 Werkwijze voor het bereiden van anti-inflammatoir werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van anti-inflammatoir werkzame oxazolopyridinen.

Country Status (17)

Country Link
JP (1) JPS5943475B2 (nl)
AR (1) AR208500A1 (nl)
AT (1) AT333277B (nl)
AU (1) AU472528B2 (nl)
BE (2) BE800868A (nl)
CA (1) CA1019741A (nl)
CS (1) CS178889B2 (nl)
DD (1) DD105237A5 (nl)
DE (1) DE2330109A1 (nl)
DK (1) DK152050C (nl)
FI (1) FI57417C (nl)
FR (1) FR2187356B1 (nl)
GB (1) GB1421619A (nl)
LU (1) LU67786A1 (nl)
NL (1) NL184836C (nl)
SE (2) SE401675B (nl)
ZA (1) ZA733760B (nl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2527321A1 (de) * 1975-06-19 1976-12-23 Merck & Co Inc Oxazol eckige klammer auf 4,5-b eckige klammer zu pyridine
JPS527992A (en) * 1975-07-04 1977-01-21 Merck & Co Inc Oxazolo *4*55b* pyridines
NL187021C (nl) * 1975-07-15 1991-05-01 Merck & Co Inc Werkwijze ter bereiding van een farmaceutisch preparaat met anti-inflammatoire werking, alsmede werkwijze ter bereiding van voor toepassing daarbij geschikte anti-inflammatoir werkzame 2-fenyl-oxazolo-(4,5-b)pyridinederivaten.
US4011326A (en) * 1975-07-29 1977-03-08 Merck & Co., Inc. 2-Substituted oxazolo[4,5-b]pyridine anti-inflammatory agents
US4753673A (en) * 1977-07-22 1988-06-28 The Dow Chemical Company Trifluoromethyl pyridinyloxyphenoxy and pyridinylthiophenoxy propanoic acids and propanols and derivatives thereof and methods of herbicidal use
EP0107866B1 (en) * 1977-08-12 1988-03-30 Imperial Chemical Industries Plc Trihalomethylpyridine compounds
JPS5461182A (en) * 1977-10-20 1979-05-17 Ishihara Sangyo Kaisha Ltd 2-phenoxy-5-trifluoromethylpyridine compounds
JPS5461183A (en) * 1977-10-21 1979-05-17 Ishihara Sangyo Kaisha Ltd 2-substituted-5-trifluoromethyl pyridine compounds
EP0003877B1 (en) * 1978-02-15 1988-02-03 Imperial Chemical Industries Plc Herbicidal derivatives of 2-(4(2-pyridyloxy)phenoxy)propane, processes for preparing them, and herbicidal compositions containing them
JPS55130840U (nl) * 1979-03-12 1980-09-16
JPS55124763A (en) * 1979-03-19 1980-09-26 Ishihara Sangyo Kaisha Ltd 5-trifluoromethyl-2-pyridone derivative
GB8333514D0 (en) * 1983-12-16 1984-01-25 Erba Farmitalia Tetrahydrothiazolo(5 4-c)pyridine derivatives
FR2652085A1 (fr) * 1989-09-20 1991-03-22 Science Organisation Nouveau procede de synthese de derives d'oxazolopyridines.
SI0937075T1 (en) * 1996-11-11 2004-06-30 Altana Pharma Ag New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors.
WO1999062908A2 (en) * 1998-06-04 1999-12-09 Abbott Laboratories Cell adhesion-inhibiting antinflammatory compounds
US6232320B1 (en) 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
WO2000075145A1 (en) * 1999-06-03 2000-12-14 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
AU2002216649A1 (en) * 2000-10-31 2002-05-15 Lynn Bonham Benzoxazole lpaat- beta inhibitors and uses thereof
US8088928B2 (en) 2005-08-04 2012-01-03 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
US8093401B2 (en) 2005-08-04 2012-01-10 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
US7855289B2 (en) 2005-08-04 2010-12-21 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
WO2007019346A1 (en) 2005-08-04 2007-02-15 Sirtris Pharmaceuticals, Inc. Benzothiazoles and thiazolopyridines as sirtuin modulators
CL2008001822A1 (es) 2007-06-20 2009-03-13 Sirtris Pharmaceuticals Inc Compuestos derivados de tiazolo[5,4-b]piridina; composicion farmaceutica que comprende a dichos compuestos; y uso del compuesto en el tratamiento de la resistencia a la insulina, sindrome metabolico, diabetes, entre otras.
AU2009285584B2 (en) * 2008-08-29 2015-04-02 Treventis Corporation Butyrylcholinesterase ligands as diagnostic tools and treatment for deseases of the nervous system
ES2544258T3 (es) 2008-12-19 2015-08-28 Glaxosmithkline Llc Compuestos de tiazolopiridina moduladores de sirtuina
WO2011040629A1 (en) * 2009-09-30 2011-04-07 Sumitomo Chemical Company, Limited Composition and method for controlling arthropod pests
AR082974A1 (es) 2010-09-15 2013-01-23 Hoffmann La Roche Derivados de azabenzotiazol, composiciones farmaceuticas que los contienen, metodo para prepararlos y uso de los mismos para tratar enfermedades inflamatorias
US8853238B2 (en) * 2010-12-24 2014-10-07 Sumitomo Chemical Company, Limited Fused heterocyclic compound and use thereof for pest control
US20170217941A1 (en) * 2014-06-25 2017-08-03 Epizyme, Inc. Substituted benzene and 6,5-fused bicyclic heteroaryl compounds
JP2017537909A (ja) 2014-12-02 2017-12-21 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 有害生物防除剤としての二環式化合物 本出願は、新規二環式化合物、それら化合物を含んでいる組成物、害虫（ａｎｉｍａｌ ｐｅｓｔ）を防除するためのそれらの使用、並びに、それらを調製するための方法及び中間体に関する。
US10399966B2 (en) 2016-01-21 2019-09-03 University Of Washington Compounds for treatment of trypanosomes and neurological pathogens and uses thereof
EP3483148B1 (en) * 2016-07-07 2023-08-23 Hodogaya Chemical Co., Ltd. Compound having benzazole ring structure and organic electroluminescent element

Also Published As

Publication number Publication date
GB1421619A (en) 1976-01-21
BE800868A (fr) 1973-12-13
FI57417C (fi) 1980-08-11
AU5651173A (en) 1974-12-05
SE7604385L (sv) 1976-04-14
JPS5943475B2 (ja) 1984-10-22
FR2187356A1 (nl) 1974-01-18
AR208500A1 (es) 1977-02-15
NL7307582A (nl) 1973-12-18
AT333277B (de) 1976-11-10
ZA733760B (en) 1975-01-29
DK152050C (da) 1988-07-18
DD105237A5 (nl) 1974-04-12
CA1019741A (en) 1977-10-25
FI57417B (fi) 1980-04-30
NL184836B (nl) 1989-06-16
BE819177R (fr) 1975-02-26
DK152050B (da) 1988-01-25
AU472528B2 (en) 1976-05-27
SE432767B (sv) 1984-04-16
CS178889B2 (en) 1977-10-31
LU67786A1 (nl) 1973-08-16
FR2187356B1 (nl) 1977-01-28
DE2330109A1 (de) 1974-01-03
JPS4961195A (nl) 1974-06-13
SE401675B (sv) 1978-05-22
ATA508673A (de) 1976-03-15

Similar Documents

Publication Publication Date Title
NL184836C (nl) Werkwijze voor het bereiden van anti-inflammatoir werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van anti-inflammatoir werkzame oxazolopyridinen.
NL168830B (nl) Werkwijze voor het bereiden van therapeutische preparaten, alsmede werkwijze voor het bereiden van daarvoor geschikte amiden.
NL173954C (nl) Werkwijze voor het bereiden van 4-amidopiperidineverbindingen en werkwijze voor het bereiden van farmaceutische preparaten.
NL162072B (nl) Werkwijze voor het bereiden van pijnstillende, anti- -narcotische geneesmiddelen, aldus verkregen gevormde geneesmiddelen,alsmede werkwijze voor het bereiden van daarvoor geschikte actieve stoffen.
NL7414946A (nl) Werkwijze voor het bereiden van farmaceutische preparaten.
NL164845B (nl) Werkwijze voor het bereiden van herbicide preparaten, die ortho-nitroanilinen bevatten, en werkwijze voor het bereiden van deze ortho-nitroanilinen.
NL179287C (nl) Werkwijze voor het bereiden van steroiden van de pregnaanreeks, werkwijze ter bereiding van farmaceutische preparaten en gevormd geneesmiddel.
NL7500167A (nl) Werkwijze voor het bereiden van cefalosporine- aten, alsmede farmaceutische preparaten eze verbindingen als actieve componenten ten.
NL144604B (nl) Werkwijze voor het bereiden van analgetisch werkzame benzazocineverbindingen, werkwijze voor het bereiden van analgetisch werkzame preparaten en gevormd geneesmiddel.
NL164287C (nl) Werkwijze voor het bereiden van farmaceutische preparaten die bufatrienoliderhamnoside-ethers bevatten, alsmede werkwijze voor het bereiden van deze bufatrienoliderhamnoside-ethers.
NL178318C (nl) Werkwijze voor het bereiden van anti-emetisch werkzame geneesmiddelen en daarvoor geschikte aktieve verbindingen.
NL153514B (nl) Werkwijze voor het bereiden van dl-15-deoxyprostaglandine-e1, prostaglandine-e1, d1-11-deoxyprostaglandine-e1 en dl-11,15-dideoxyprostaglandine-e1.
NL174251C (nl) Werkwijze voor het bereiden van farmaceutische preparaten op basis van indoolderivaten, alsmede werkwijze ter bereiding van indoolderivaten.
NL149181B (nl) Werkwijze voor het bereiden van insekticide preparaten, die fosforoamidothioaatderivaten bevatten en werkwijze voor het bereiden van deze fosforoamidothioaatderivaten.
NL175621C (nl) Werkwijze voor het bereiden van benzazepinen en farmaceutische preparaten daaruit.
NL157655B (nl) Werkwijze voor het bereiden van een antibioticum en antibioticum-preparaten, alsmede gevormd genees- of ontsmettingsmiddel.
NL175827C (nl) Werkwijze voor het bereiden van alfa-(5-indanyloxycarbonyl)-benzylpenicilline en van farmaceutische preparaten daaruit.
NL176746C (nl) Werkwijze voor het bereiden van farmaceutische preparaten met antihypertensieve werking, alsmede voortbrengselen verkregen door toepassing hiervan.
NL166935C (nl) Werkwijze voor het bereiden van kalmerend werkzame benzodiazepinonen, alsmede werkwijze ter bereiding van farmaceutische preparaten met daarin de aldus bereide verbindingen.
NL175813C (nl) Werkwijze voor het bereiden van preparaten met een insecticide werking alsmede werkwijze ter bereiding van 2-buteenzuurderivaten, geschikt voor toepassing in dergelijke preparaten.
NL142416B (nl) Werkwijze voor het bereiden van 6-amino-acylaminopenicillanzuren, alsmede werkwijze voor de bereiding van farmaceutische preparaten.
NL150993B (nl) Werkwijze voor het bereiden van herbicide preparaten.
NL184834C (nl) Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van voor toepassing daarbij geschikte, antibacterieel werkzame cycloserinederivaten.
NL7514038A (nl) Werkwijze voor het bereiden van octahydromorfantri- dinederivaten, werkwijze voor het bereiden van far- maceutische preparaten met toepassing daarvan als- mede zo gevormde preparaten.
NL178971C (nl) Werkwijze ter bereiding van antibiotisch werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van voor toepassing daarbij geschikte cefalosporinederivaten.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BK Erratum

Free format text: CORRECTION TO PAMPHLET

V1 Lapsed because of non-payment of the annual fee